X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. DIVIS LABORATORIES FDC LTD./
DIVIS LABORATORIES
 
P/E (TTM) x 21.5 37.6 57.2% View Chart
P/BV x 4.8 6.1 79.3% View Chart
Dividend Yield % 1.0 0.7 133.0%  

Financials

 FDC LTD.   DIVIS LABORATORIES
EQUITY SHARE DATA
    FDC LTD.
Mar-14
DIVIS LABORATORIES
Mar-18
FDC LTD./
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1441,142 12.6%   
Low Rs79533 14.8%   
Sales per share (Unadj.) Rs47.6146.6 32.4%  
Earnings per share (Unadj.) Rs7.633.0 23.0%  
Cash flow per share (Unadj.) Rs9.038.4 23.5%  
Dividends per share (Unadj.) Rs2.2510.00 22.5%  
Dividend yield (eoy) %2.01.2 169.4%  
Book value per share (Unadj.) Rs47.5222.8 21.3%  
Shares outstanding (eoy) m177.83265.47 67.0%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.35.7 40.9%   
Avg P/E ratio x14.625.3 57.7%  
P/CF ratio (eoy) x12.321.8 56.6%  
Price / Book Value ratio x2.33.8 62.3%  
Dividend payout %29.630.3 97.7%   
Avg Mkt Cap Rs m19,784222,318 8.9%   
No. of employees `000NA10.8 0.0%   
Total wages/salary Rs m1,2214,561 26.8%   
Avg. sales/employee Rs ThNM3,616.0-  
Avg. wages/employee Rs ThNM423.8-  
Avg. net profit/employee Rs ThNM814.9-  
INCOME DATA
Net Sales Rs m8,45938,915 21.7%  
Other income Rs m3941,134 34.7%   
Total revenues Rs m8,85240,049 22.1%   
Gross profit Rs m2,07012,617 16.4%  
Depreciation Rs m2491,425 17.5%   
Interest Rs m3113 233.2%   
Profit before tax Rs m2,18412,313 17.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6063,543 17.1%   
Profit after tax Rs m1,3538,770 15.4%  
Gross profit margin %24.532.4 75.5%  
Effective tax rate %27.728.8 96.4%   
Net profit margin %16.022.5 71.0%  
BALANCE SHEET DATA
Current assets Rs m4,35545,351 9.6%   
Current liabilities Rs m1,7926,507 27.5%   
Net working cap to sales %30.399.8 30.4%  
Current ratio x2.47.0 34.9%  
Inventory Days Days44127 35.1%  
Debtors Days Days2595 25.9%  
Net fixed assets Rs m3,02521,160 14.3%   
Share capital Rs m179531 33.6%   
"Free" reserves Rs m8,24358,625 14.1%   
Net worth Rs m8,45359,156 14.3%   
Long term debt Rs m110-   
Total assets Rs m10,55767,832 15.6%  
Interest coverage x71.4926.8 7.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 139.7%   
Return on assets %13.112.9 101.3%  
Return on equity %16.014.8 108.0%  
Return on capital %23.520.8 112.8%  
Exports to sales %13.30-   
Imports to sales %3.321.8 15.3%   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m2838,485 3.3%   
Fx inflow Rs m1,14632,359 3.5%   
Fx outflow Rs m3559,042 3.9%   
Net fx Rs m79123,317 3.4%   
CASH FLOW
From Operations Rs m1,4857,759 19.1%  
From Investments Rs m-620-4,783 13.0%  
From Financial Activity Rs m-753-3,142 24.0%  
Net Cashflow Rs m113-166 -68.0%  

Share Holding

Indian Promoters % 68.9 52.0 132.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 11.8 39.8%  
FIIs % 7.5 19.0 39.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 17.2 110.5%  
Shareholders   23,730 31,796 74.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   GSK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare FDC LTD. With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; Realty & Auto Stocks Top Losers(09:30 am)

Asian shares eased in holiday-thinned trading on Monday and the safe haven yen gained as China canceled upcoming tariff talks with the United States.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY19); Net Profit Up 50.8% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 50.8% YoY). Sales on the other hand came in at Rs 10 bn (up 21.2% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 24, 2018 12:37 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - IPCA LABS COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS